Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] RISK stratification in paediatric Crohn’s disease

“Speak up. Step up. Stand out.” With this slogan for the fifth annual Crohn’s and Colitis Awareness Week, the Crohn’s & Colitis Foundation of America was asking everyone to raise awareness of Crohn’s disease and ulcerative colitis. Despite the invisible nature of these incurable diseases, patients with inflammatory bowel disease have symptoms including severe abdominal pain, weight loss, and diarrhoea. The onset of Crohn’s disease is characterised most often by an inflammatory phenotype; most patients develop stricturing or penetrating complications, or both, over time.